Summary: The Deepbridge Life Sciences EIS is a discretionary portfolio service that will invest into a portfolio of up to 10 underlying companies, focusing on start-up or early-stage life science companies.
Strategy: Well defined investment process to invest directly in new companies in selected technology areas.
Concentration: Portfolio may be up to 10 investments, although smaller investors may get greater concentration.
Team: The Deepbridge team is very experienced in the relevant areas, and its Committees have very strong outside members.
Newer product area: Although Deepbridge has been investing in EIS since 2013, dedicated Life Science products are a relatively new area.